Cetylpyridinium Chloride KIN Products for Clinics

Several products from Laboratorios KIN contain cetylpyridinium chloride (CPC) as an antiseptic and are therefore suitable for preventing or minimising the risk of infection with certain viruses.

Specifically KIN GINGIVAL COMPLEX and GINGIKIN B5, our reference brands in professional oral hygiene and treatment.

KIN GINGIVAL COMPLEX

KIN GINGIVAL COMPLEX ENJ. BANK 5 L

VIEW PRODUCT

KIN GINGIVAL COMPLEX RINSE 1L X 2

VIEW PRODUCT

KIN GINGIVAL COMPLEXMouthwash contains 0.05% free CPC, which is within the range suggested effective for reducing viral load. It would therefore be ideal for oral hygiene prior to intraoral examination or intervention.

On the other hand, we would like to remind you that KIN GINGIVAL COMPLEX was already being used in consultation to reduce the bacterial load due to its content in chlorhexidine, which due to its wide spectrum of action against gram + and gram - microorganisms continues to be the most effective antiseptic agent in the control of biofilm. KIN GINGIVAL COMPLEX also contains the Alpantha complex as a differential agent, which gives it toning and strengthening properties on mucous membranes and gums.

Discover the KIN GINGIVAL COMPLEX range in our professional portal

GINGIKIN B5

GINGIKIN B5 is the line designed for the maintenance and daily care of the gums. Its formula, in addition to 0.05% CPC, contains provitamin B5 , vitamin B3 , fluoride and xylitol in order to provide complete protection to the oral cavity.

We are sure that these two products will contribute to the protection of both the team and the patients in the dental clinic. Below you will find links for further information.

In our professional portal you have all the details about the GINGIKIN B5 products. More information here.

GINGIKIN PACK B5

VIEW PRODUCT

GINGIKIN B5 RINSE 1 L

VIEW PRODUCT

Bibliography: 1. Strategic plan of action for the period after the crisis created by the COVID-19. Consejo de Dentistas. Spanish Dental Association. April 2020. 2. Basso M, Bordini G, Bianchi F, Prosper L, Testori T, Del Fabbro M. Utilizzo di collutori preoperativi contro il virus SARS-CoV-2 (COVID-19): revisione della letteratura e raccomandazioni cliniche. Quintessenza Internazionale, issue 1-2020. 3. Popkin DL, Zilka S, Dimaano M, Fujioka H, Rackley C, Salata R, Griffith A, Mukherjee PK, Ghannoum MA, Esper F. Cetylpyridinium chloride (CPC) exhibits potent, rapid activity against influenza viruses in vitro and in vivo. Pathogens and Immunity. 2017;2(2):253-69. 4. Wölfel, R., Corman, V.M., Guggemos, W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature (2020). Mukherjee PK, Esper F, Buchheit K, Arters K, Adkins I, Ghannoum MA et al. Randomized, double-blind, place¬bo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. BMC Infect Dis. 2017 Jan 14;17(1):74 6. Gerardo Ruales-Suárez DDS. MSc. PhD. Preventive measures from a dental perspective against SARS-CoV-2: Nasal Respiration and Cetylpyridinium Chloride (CPC) mouthwashes. - 2020/04/14. https://www.academia.edu/42767233/Covid_Ruales_English?auto=download